ACE1702

· Acepodia Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACE1702, covering 2024-12-05 to 2024-12-05. Get the full timeline:

Most recent: Clinical Trial Update: ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors [Phase 1]